Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hommel

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
La Revue Du Praticien|September 28, 2006
[Stroke centers and stroke networks]Marc Hommel, France Woimant
International Journal of Stroke : Official Journal of the International Stroke Society|October 30, 2013
Depression: cognition relations after strokeMarc Hommel, Leeanne Carey, Assia Jaillard
International Journal of Stroke : Official Journal of the International Stroke Society|September 9, 2017
Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatmentOlivier Detante, Anaïck Moisan, Marc Hommel, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 22, 2003
The French stroke programMarc Hommel, Alain Deblasi, Katia Garambois, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 21, 2012
Pathophysiologic cascades in ischemic strokeChanghong Xing, Ken Arai, Eng H Lo, et al.
The New England Journal of Medicine|July 18, 1996
Thrombolytic therapy with streptokinase in acute ischemic stroke, Marc Hommel, C Cornu, et al.
Translational Stroke Research|August 9, 2016
How to Measure Recovery? Revisiting Concepts and Methods for Stroke StudiesMarc Hommel, Olivier Detante, Isabelle Favre, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 6, 2010
Predicting cognitive dysfunctioning in nondemented patients early after strokeAssia Jaillard, Sylvie Grand, Jean François Le Bas, et al.
Plos One|October 11, 2021
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sampleJean-Pierre Boissel, David Pérol, Hervé Décousus, et al.
Progress in Biophysics and Molecular Biology|December 14, 2007
A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patientsMarie-Aimée Dronne, Emmanuel Grenier, Guillemette Chapuisat, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
La Revue Du Praticien|September 28, 2006
[Stroke centers and stroke networks]Marc Hommel, France Woimant
International Journal of Stroke : Official Journal of the International Stroke Society|October 30, 2013
Depression: cognition relations after strokeMarc Hommel, Leeanne Carey, Assia Jaillard
International Journal of Stroke : Official Journal of the International Stroke Society|September 9, 2017
Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatmentOlivier Detante, Anaïck Moisan, Marc Hommel, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 22, 2003
The French stroke programMarc Hommel, Alain Deblasi, Katia Garambois, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 21, 2012
Pathophysiologic cascades in ischemic strokeChanghong Xing, Ken Arai, Eng H Lo, et al.
The New England Journal of Medicine|July 18, 1996
Thrombolytic therapy with streptokinase in acute ischemic stroke, Marc Hommel, C Cornu, et al.
Translational Stroke Research|August 9, 2016
How to Measure Recovery? Revisiting Concepts and Methods for Stroke StudiesMarc Hommel, Olivier Detante, Isabelle Favre, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 6, 2010
Predicting cognitive dysfunctioning in nondemented patients early after strokeAssia Jaillard, Sylvie Grand, Jean François Le Bas, et al.
Plos One|October 11, 2021
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sampleJean-Pierre Boissel, David Pérol, Hervé Décousus, et al.
Progress in Biophysics and Molecular Biology|December 14, 2007
A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patientsMarie-Aimée Dronne, Emmanuel Grenier, Guillemette Chapuisat, et al.
Pageof 5